Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

SHA:600557 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	3,313	3,293	3,898	4,864	4,351	3,649
Revenue Growth	0.96%	-15.52%	-19.86%	11.79%	19.25%	20.34%
Gross Profit Gross Profit Growth	2,380	2,332	2,833	3,610	3,137	2,625
Operating Income Operating Income Growth	242.78	249.06	293.24	409.53	399	320.11
Net Income Net Income Growth	308.72	303.93	391.86	464.16	434.47	320.54
Earnings Per Share EPS Growth	0.55	0.54	0.68	0.80	0.75	0.56
EPS Growth	5.98%	-20.59%	-15.00%	6.67%	33.93%	27.27%

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,957	2,148	2,235	2,439	1,771	1,113
Total Debt Total Debt Growth	0.79	407.36	488.01	424.66	1.93	236.43
Net Cash (Debt) Net Cash Growth	1,956	1,741	1,747	2,014	1,769	877.01
Net Cash Growth	-5.90%	-0.36%	-13.27%	13.84%	101.75%	209.48%
Net Cash Per Share Net Cash Per Share Growth	3.49	3.09	3.03	3.47	3.05	1.53

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	548.34	610.59	702.49	972.32	995.94	908.3
Capital Expenditures CapEx Growth	-601.76	-521.78	-476.69	-311.29	-211.09	-171.52
Free Cash Flow Free Cash Flow Growth	-53.42	88.81	225.8	661.03	784.85	736.77
Free Cash Flow Growth	-	-60.67%	-65.84%	-15.78%	6.53%	44.24%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	71.84%	70.81%	72.69%	74.22%	72.11%	71.95%
Operating Margin	7.33%	7.56%	7.52%	8.42%	9.17%	8.77%
Pretax Margin	10.61%	10.83%	9.87%	9.21%	10.24%	9.00%
Profit Margin	9.32%	9.23%	10.05%	9.54%	9.99%	8.79%
FCF Margin	-1.61%	2.70%	5.79%	13.59%	18.04%	20.19%

Dividends

Chart

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Dividend Per Share Dividend Per Share Growth	0.372	0.220
Dividend Per Share Growth	69.11%	-
Dividend Yield	1.85%	1.21%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	22.25	26.28	19.79	25.85	25.23	22.01
Forward PE	20.23	14.69	12.25	19.80	22.32	16.11
P/FCF Ratio	-	89.95	34.35	18.15	13.97	9.58
PS Ratio	2.09	2.43	1.99	2.47	2.52	1.93

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error